Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Sarfez Pharmaceuticals Inc
Profile last edited on: 12/29/17      CAGE: 5F4F2      UEI: YRJBXMC3Y9W6

Business Identifier: Drug development
Year Founded
2012
First Award
2013
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1600 Tysons Boulevard Suite 800 8th Floor
Mclean, VA 22102
   (703) 627-1934
   N/A
   www.sarfez.com
Location: Multiple
Congr. District: 11
County: Fairfax

Public Profile

Sarfez Pharmaceuticals, Inc. is focused on improving existing drugs using proprietary extended release formulation technology, repurposing older drugs for new uses and designing new molecules to target specific patient needs to treat cardiovascular and kidney diseases.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$276,085
Phase II Dollars
$1,987,476
Total Awarded
$2,263,561

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 2 NIH $2,263,561
Project Title: Extended Release Torsemide

Key People / Management

  Peter Uri Feig -- Chief Medical Officer

  Fatima Khwaja -- Chief Executive Officer

Company News

There are no news available.